The FDA has approved Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of fibromyalgia in adults.

A plan for tapering opioids should be developed to minimize withdrawal symptoms in children receiving opioids for 5 or more days.

Living in historically redlined areas is associated with a lack of rapid access to emergency medical services.

Non-depressive affective symptoms, such as apathy, were associated with increased mortality in older adults with dementia.

Higher HDL-C was associated with improved cognitive performance scores at midlife among women during the menopause transition.

Response to early treatment significantly predicted clinical and functional trajectories associated with lower symptom severity.

Several classes of parental occupational exposures are associated with autism spectrum disorder severity and several behavioral subscales.

Neuroanatomical variability is associated with early substance use initiation, according to a cohort study published in JAMA Network Open.

HealthDay News — The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management. Ketamine is the only psychedelic or psychedelic-adjacent drug on ...

There is a weak correlation between change in cognitive impairment and change in work productivity loss in adults with bipolar disorder.

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.

Among boys and girls, as within-person smoking rates increased, acute mood boost immediately after smoking became more stable.